Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04068753
Title Niraparib in Combination With TSR-042 in Patients With Recurrent or Progressive Cervix Cancer (STAR)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Oklahoma
Indications

cervical cancer

Therapies

Dostarlimab-gxly + Niraparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Montefiore Medical Center Active, not recruiting Bronx New York 10461 United States Details
University of North Carolina Terminated Chapel Hill North Carolina 27514 United States Details
Stephenson Cancer Center Recruiting Oklahoma City Oklahoma 73104 United States Details
University of Virginia Cancer Center Recruiting Charlottesville Virginia 22903 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field